A Long-Term Study in Patients With Amyotrophic Lateral Sclerosis (ALS)
Status:
Completed
Trial end date:
2017-03-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the safety and efficacy of long-term E0302
administration in patients with Amyotrophic Lateral Sclerosis (ALS).